Marianna Macerelli
Udine, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Corrigendum to 'Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study' [Cancer Treat Res Commun. 2026:47:101143].
Journal: Cancer treatment and research communications
Published: August 25, 2026
Response to Letter Re: Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the ISTOP study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 10, 2026
Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the I-STOP study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 25, 2025
Advanced-stage ALK-positive non-small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 16, 2025
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 17, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Journal: Journal for immunotherapy of cancer
Published: July 31, 2025
Retrospective evaluation of the "neutrophil-lymphocyte ratio" (NLR) in patients affected by locally advanced unresectable stage III NSCLC treated with Durvalumab within the Italian expanded access program (EAP): results of the neutrality trial.
Journal: Cancer treatment and research communications
Published: July 22, 2025
APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer.
Journal: NPJ precision oncology
Published: April 03, 2025
Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.
Journal: Cancer treatment and research communications
Published: March 24, 2025
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Journal: Journal for immunotherapy of cancer
Published: December 29, 2024
Steroid-sparing strategies for managing ICI-induced arthritis: safety and oncological outcomes.
Journal: Clinical and experimental rheumatology
Published: December 12, 2024
The Role of ctDNA in the Management of Non-Small-Cell Lung Cancer in the AI and NGS Era.
Journal: International journal of molecular sciences
Published: November 12, 2024
Last Updated: 09/26/2026